CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether it can give rise to secondary cancers.
FDA warns of risks from cancer treatments
8 New FDA-Approved Drugs in May 2023 ⋆ Vial
Wafik S. El-Deiry, MD, PhD, FACP on X: Now they have and meanwhile FDA has a new boxed warning for CAR-T drugs. / X
FDA, Latest News, Photos & Videos
Most Recent, Page 42
Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation, Molecular Cancer
Aptamers: Cutting edge of cancer therapies - ScienceDirect
Kris Atkins on LinkedIn: It is hard to believe how quickly things are moving in GCT. Exciting…
Vaibhav Bhatia posted on LinkedIn
:max_bytes(150000):strip_icc()/VWH-SydneySaporito-PotentialTreatmentsAvailableforMenWithBreastCancer-Standard-a8ef13bc3f2840cd956389e14c520f3b.jpg)
